Clinical Trial Update: Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) [NA]

View source ↗

Summary

A pilot trial evaluating sirolimus in combination with MEC chemotherapy for high-risk acute myeloid leukemia has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Etoposide (Etoposide)
• Mitoxantrone (mitoxantrone)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: AML | NA | Status: COMPLETED | Results posted: 2014-08-27